Delivery Order SPE2DB22D9304-SPE2DB25FSTC4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,087.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Thiola EC 100 mg tablets (300 count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $6,087.32 for 300 tablets of Thiola EC 100 mg on July 25, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed in Park Ridge, Illinois. This award does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,087.32 contract is for the delivery of Thiola EC 100 mg tablets and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $6,370.06, is for the supply of THIOLA EC 100 MG TABLET 300S, a pharmaceutical product. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA worth up to $499,999,999, which enables the DLA to issue firm fixed-price delivery orders...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,087.32 to DMS Pharmaceutical Group Inc. for 300 tablets of Thiola EC 100 mg. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,740.12, is for the delivery of Thiola EC 100 mg tablets to DLA. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC, under the SPE2DB program,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $6,370.06 for the supply of Thiola EC 100 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the DLA to issue firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,087.32 firm fixed-price delivery order is for the provision of 300 units of the prescription drug Thiola EC 100 mg tablets. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of THIOLA EC 100 MG TABLET 300S, a pharmaceutical product, with a ceiling value of $12,740.12 and an ultimate completion date of May 31, 2024. The contract is a firm-fixed-price delivery order that is part of a larger indefinite delivery contract (IDC) vehicle,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,370.06 award is for the supply of THIOLA EC 100 MG TABLET 300S, with a period of performance through September 18, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB25FSTC4Delivery Order
The Defense Logistics Agency awarded a $12,174.66 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 23, 2025, for the supply of Thiola EC 100 mg tablets (300 count). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. This award was made without a set-aside designation, and the ultimate completion date is October 15, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, awarded under the SPE2DB program, enables DLA to procure a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support medical supply requirements for military health facilities worldwide. DMS Pharmaceutical Group's status as a woman-owned small business and its extensive pharmaceutical supply portfolio have established the company as a critical supplier within the federal pharmaceutical supply chain supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 9/23/25 |